Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Alere Inc. ("Alere" or the "Company") (NYSE: ALR) concerning possible violations of federal securities laws between February 29, 2012 and November 4, 2016 inclusive (the "Class Period"). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm in advance of the January 13, 2017 lead plaintiff motion deadline. To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at email@example.com. No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member. According to the Complaint, Alere made false and misleading statements and/or failed to disclose: that the Company's wholly-owned subsidiary, Arriva Medical, LLC ("Arriva"), was submitting claims to Medicare for deceased patients; that this conduct subjected Arriva to revocation of its Medicare enrollment; and that as a result of the above, Alere's statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times. On November 4, 2016, Alere announced that the Centers for Medicare and Medicaid Services alleged that Arriva submitted claims for 211 deceased patients over a five-year period, and thus revoked Arriva's Medicare enrollment.